Workflow
科思股份(300856) - 2024 Q1 - 季度财报
COSMOSCOSMOS(SZ:300856)2024-04-16 13:34

Financial Performance - The company's operating revenue for Q1 2024 was ¥711,843,765.01, representing a 21.10% increase compared to ¥587,793,946.66 in the same period last year[19] - The net profit attributable to shareholders for Q1 2024 was ¥219,777,234.42, which is a 37.16% increase from ¥160,229,516.90 in the previous year[19] - The company reported a total operating cost of ¥474,115,510.18 for Q1 2024, up from ¥396,559,739.94 in the same quarter last year[14] - The company reported a significant increase in other income to ¥15,751,903.07 from ¥1,731,636.13, suggesting improved operational efficiency[14] - The company reported a comprehensive income total of ¥220,203,654.40, compared to ¥159,302,758.76 in the previous year[34] - The company's non-recurring profit and loss attributable to shareholders was ¥203,942,693.27, up 29.78% from ¥157,144,785.08 in the previous year[38] Assets and Liabilities - The total liabilities as of March 31, 2024, amounted to ¥1,247,062,063.07, a slight decrease from ¥1,263,457,776.02 at the end of the previous period[13] - The total equity attributable to shareholders increased to ¥2,858,576,438.80 from ¥2,626,950,500.64, reflecting a positive growth in shareholder value[13] - The total assets as of March 31, 2024, were reported at ¥4,135,181,256.66, up from ¥3,890,408,276.66, reflecting overall growth in the company's financial position[13] - The total liabilities decreased from CNY 494,224,813.95 to CNY 453,000,897.99, indicating a decline of approximately 8.4%[48] - The company's accounts payable decreased to CNY 323,828,533.98 from CNY 363,046,477.37, a reduction of about 10.8%[48] Cash Flow - The net cash flow from operating activities was ¥161,229,326.64, a decrease of 6.24% compared to ¥171,958,040.51 in the previous year[38] - Operating cash inflow for the current period was CNY 699,458,266.44, an increase of 13.39% from CNY 616,742,358.18 in the previous period[69] - Cash outflow from operating activities totaled CNY 538,228,939.80, up 21.06% from CNY 444,784,317.67 in the prior period[69] - Net cash flow from operating activities decreased to CNY 161,229,326.64, down 6.93% from CNY 171,958,040.51 year-over-year[69] - Cash received from investment recovery was CNY 530,000,000.00, indicating a significant inflow from investments[69] Investments and Growth - Research and development expenses for Q1 2024 were ¥31,828,887.16, slightly higher than ¥31,263,696.98 in the previous year, indicating continued investment in innovation[14] - The company is expanding its product lines, which is expected to further enhance revenue growth in the upcoming quarters[41] - The company successfully acquired the land use rights for a state-owned construction site, enhancing its operational capacity[9] - Deferred income increased to ¥35,020,417.51 from ¥26,371,130.99, indicating growth in future revenue recognition[13] - The company has seen a continuous increase in revenue from its main business due to growing market demand for active ingredients and raw materials in cosmetics[41] Shareholder Value - The basic earnings per share increased to ¥1.2979, up 37.16% from ¥0.9463 in the same period last year[38] - The total equity attributable to shareholders of the listed company increased to ¥2,858,576,438.80, an increase of 8.82% from ¥2,626,950,500.64 at the end of the previous year[38] - The company's total liabilities decreased, contributing to an increase in the return on equity to 8.01% from 7.91%[38] Government Support and Bonds - The company received government subsidies amounting to CNY 15,512,778.20, which are closely related to its normal business operations[57] - The company decided not to exercise the early redemption rights for the "Kosi Convertible Bonds" to protect investor interests[45] - The company plans to reassess the early redemption of the "Kosi Convertible Bonds" after September 22, 2024, if the conditions are triggered again[45]